Feasibility and Effects of Noninvasive Brain Stimulation on Pain Perception in People With Fibromyalgia

NCT ID
NCT07644221
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Pulkit Grover
Conditions
Fibromyalgia (FM)

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Transcranial Electrical Stimulation for Noninvasive Study of Pain Circuits in Patients With Chronic Pain

Enrollment: 50 participants (Estimated).

What is being studied

  • Intervention: Behavioral Disciplines and Activities
  • Intervention: Convulsive Therapy
  • Intervention: Electric Stimulation Therapy
  • Intervention: Electroshock
  • Device: Occipital Lobe Stimulation
  • Device: Primary Motor Cortex Stimulation
  • Intervention: Psychiatric Somatic Therapies
  • Intervention: Psychological Techniques
  • Intervention: Therapeutics
  • Intervention: Transcranial Direct Current Stimulation

Who may be eligible

Ages
18 Years to 65 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Formal diagnosis of fibromyalgia made by a practicing physician * Pain resistant to common analgesics and medications for chronic pain * Existing pain for more than 3 months with an average of at least 4 on a 0 to 10 Numerical Rating Scale (NRS) * Females of child bearing potential must be at least one of the following totally abstinent from heterosexual intercourse since the last menses before start of study, or agree to concurrent use of at least two methods of birth control throughout study participation. Exclusion Criteria: * If the subject is non-ambulatory. * If the subject is female of child-bearing potential, subject must not be pregnant. * Subject must not have a history of brain surgery or uncontrolled neurological conditions, such as seizure, fainting spells, transient ischemic attack. * Subject must not have lifetime history of severe, uncontrolled mood disorders (anxiety, depression, bipolar), psychotic disorders, other neural disorders, or heart disease. * Subject must not have any implanted electronic or metallic devices. * Subject must not have heart diseases, including known arrhythmia, or severe liver or severe gastrointestinal disease or chronic severe infectious disease (e.g. HIV/AIDS).

Study locations

2 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • Pennsylvania, United States: 2

Sample of listed locations

  • Carnegie Mellon University — Pittsburgh, Pennsylvania, 15213, United States — Site recruitment status not specified in the registry data
  • UPMC Pain Management — Pittsburgh, Pennsylvania, 15206, United States — Site recruitment status not specified in the registry data

Study details

Start date
June 1, 2026
Primary completion date
May 1, 2027
Completion date
December 1, 2027
First posted
June 12, 2026
Collaborators
Department of Anesthesiology & Perioperative Medicine, University of Pittsburgh, University of Pittsburgh Clinical and Translational Science Institute (CTSI)

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07644221
Registry last updated
June 12, 2026
QualifiedStudies registry data refreshed
October 2, 2026
QualifiedStudies record fetched
October 2, 2026

View NCT07644221 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ